Viking Therapeutics, Inc. (FRA:1VT)
Germany · Delayed Price · Currency is EUR 25.80
-0.51 (-1.94%)
Last updated: Jan 28, 2026, 3:44 PM CET
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of €2.76 billion as of January 30, 2026. Its market cap has decreased by -26.82% in one year.
Market Cap
2.76B
Enterprise Value
2.16B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€25.80
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from 73.59M to 2.76B, an increase of 3,654.68%. That is a compound annual growth rate of 40.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.76B | -18.42% |
| Dec 31, 2025 | 3.39B | -21.80% |
| Dec 31, 2024 | 4.33B | 157.18% |
| Dec 29, 2023 | 1.68B | 149.68% |
| Dec 30, 2022 | 674.52M | 113.16% |
| Dec 31, 2021 | 316.44M | -5.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |